Titan Q4 Results: Titan Company reported a robust 35% growth in net profit for Q4FY26, reaching Rs 1,179 crore, driven by a strong performance in its jewellery segment. The company’s total income surged by 46% to Rs 20,300 crore. Titan’s Board also recommended a dividend of Rs 15 per equity share.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,